deltatrials

University of British Columbia Clinical Trials

Sponsors / University of British Columbia

716 ClinicalTrials.gov entries name University of British Columbia as the lead sponsor. Of these, 70 are recruiting, 12 are active without new recruitment, and 394 have completed. The registry records 37 terminated or withdrawn trials for University of British Columbia. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Planned participant enrollment across these trials sums to 637,626. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.

716
Total Trials
70
Recruiting
12
Other Active
394
Completed
37
Terminated / Withdrawn
637,626
Total Enrollment

Termination reasons: Other49% · Recruitment49% · Efficacy3%

Recent Terminations

  • NCT06450522 Phase NA Stopped Feb 2025
    Heart Failure with Reduced Ejection Fraction HFrEF
    "Slow recruitment"
  • NCT04955470 Phase PHASE1/PHASE2 Stopped Oct 2023
    Suicidal Ideation
    "There were challenges with recruitment in the ED due to ED staffing shortages and we were unable to meet the expected recruitment rate. The decision to stop study recruitment was solely due to operational and logistical limitations."
  • NCT06153186 Phase PHASE2 Stopped May 2023
    Childhood Absence Epilepsy
    "The enrollment wasn't as predicted. We didn't have enough numbers to show statistical significance."
  • NCT04011202 Phase NA Stopped Apr 2022
    Stroke
    "Due to COVID-19; lack of recruitment; staff turnover."
  • NCT03153540 Phase NA Stopped Feb 2022
    Primary Progressive Nonfluent Aphasia
    "Lack of recruitment"
  • NCT04337385 Phase NA Stopped Mar 2020
    Cardiovascular Risk Factor
    "COVID-19 resulted in laboratory closures and the student has changed their research project in order to progress in their degree."
  • NCT04323969 Phase NA Stopped Mar 2020
    Osteoarthritis, Knee
    "COVID-related laboratory shutdown."
  • NCT03362671 Phase NA Stopped Sep 2019
    Obstructive Sleep Apnea
    "the initial design of the novel oral appliance proved uncomfortable and thus terminated trial after three subjects."
  • NCT03635671 Stopped Jul 2019
    Diabetic Retinopathy
    "Unexpected poor enrollment"
  • NCT02909231 Stopped Dec 2017
    Wounds and Injuries
    "Failed to recruit sufficient subjects"

Active Trials (12 total)

Top Conditions

Top Locations